2022
DOI: 10.1182/blood-2022-165007
|View full text |Cite
|
Sign up to set email alerts
|

Targeting of G3BP2 Refines Prognosis and Synergizes with Venetoclax in Acute Myeloid Leukemia

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles